Management of Childhood Iron Deficiency Anemia in a Developed Country-A Multi-Center Experience from Croatia

Izabela Kranjčec1, Nuša Matijašić Stjepović1, Domagoj Buljan1

  • 1Department of Oncology and Hematology, Children's Hospital Zagreb, 10000 Zagreb, Croatia.

PubMed

Insights

Childhood iron deficiency anemia (IDA) is a significant health issue in Croatia. Improved primary care diagnostics and consistent guideline implementation are crucial for managing this condition effectively.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Background:

  • Childhood iron deficiency anemia (IDA) remains a global health concern, with limited epidemiological data specific to Croatia.
  • IDA significantly impacts child health, necessitating a thorough understanding of its prevalence and management within the country.

Purpose of the Study:

  • To determine the frequency, causes, and management of childhood IDA in Croatia.
  • To analyze diagnostic practices and treatment regimens for IDA in tertiary care settings.
  • To identify variations in care and inform strategies for improved pediatric hematology services.

Main Methods:

  • Retrospective analysis of medical records for children referred for iron deficiency over five years.
  • Data collected from tertiary pediatric hematology centers across Croatia (Zagreb, Rijeka, Split, Osijek).
  • Inclusion of 864 children, primarily preschool-aged, referred by primary care physicians.

Main Results:

  • Inadequate nutrition was a common cause, with one-third of patients symptomatic.
  • Primary care physicians often performed basic diagnostics but delayed oral iron therapy initiation.
  • Dextriferron was the preferred parenteral iron formulation; compliance rates varied (63.5-93.2%).
  • Significant variations observed in hospitalization (9.4-35%), transfusion policies (6.4-22.9%), and parenteral iron use (0.3-21.5%) across centers.

Conclusions:

  • Childhood IDA poses a substantial burden even in high-income countries like Croatia.
  • Consistent implementation of national guidelines and enhanced education for primary care providers are essential.
  • Addressing diagnostic and therapeutic inconsistencies can improve outcomes for children with IDA.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
947
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
170
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K